Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells

被引:34
作者
Vares, Guillaume [1 ]
Sai, Sei [2 ]
Wang, Bing [1 ]
Fujimori, Akira [1 ]
Nenoi, Mitsuru [1 ]
Nakajima, Tetsuo [1 ]
机构
[1] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, Chiba 2638555, Japan
[2] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan
关键词
Progesterone; Cancer stem cells; Basal breast cancer; Membrane progesterone receptor; Radiation; miRNA; BREAST-CANCER; EXPRESSION; RADIATION; GROWTH; MAINTENANCE; INVOLVEMENT; RESISTANCE; INHIBITION; SNAIL; IDENTIFICATION;
D O I
10.1016/j.canlet.2015.03.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ionizing radiation and cumulative exposure to steroid hormones are known risk factors for breast cancer. There is increasing evidence that breast tumors are driven by a subpopulation of tumor-initiating cancer stem cells (CSCs). In MCF10A non-cancerous basal-like PR- cells, progesterone treatment and X-rays generated ALDH(+) and CD44(+)/CD24(-) CSCs. Here, we report that in irradiated MCF10A cells, progesterone activated the PI3K/Akt pathway via membrane progesterone receptor (mPR). Inhibition of the PI3K/Akt pathway counteracted the generation of CSCs by progesterone and irradiation. The stimulation of PI3K/Akt via mPR resulted in the inactivation of FOXO transcriptional activity, the upregulation of snail and slug expression and a downregulation of miR-29 expression, which led to increased levels of KLF4, a transcription factor required for breast CSC maintenance. Stabilization of miR-29 expression impeded the generation of CSCs, while its inhibition alone was sufficient to generate CSCs. This study provides a new mechanistic basis for progesterone and radiation-induced breast cancer risk in basal cells. In addition, the elucidation of new pathways and miRNA regulations involved in CSC generation and maintenance may open the door to potential novel anti-CSC strategies. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 68 条
[1]   Stem cells in breast tumours: Are they ready for the clinic? [J].
Ablett, Matthew P. ;
Singh, Jagdeep K. ;
Clarke, Robert B. .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (14) :2104-2116
[2]   KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERα [J].
Akaogi, K. ;
Nakajima, Y. ;
Ito, I. ;
Kawasaki, S. ;
Oie, S-H ;
Murayama, A. ;
Kimura, K. ;
Yanagisawa, J. .
ONCOGENE, 2009, 28 (32) :2894-2902
[3]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[4]   TGFβ/TNFα-Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype [J].
Asiedu, Michael K. ;
Ingle, James N. ;
Behrens, Marshall D. ;
Radisky, Derek C. ;
Knutson, Keith L. .
CANCER RESEARCH, 2011, 71 (13) :4707-4719
[5]   Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells [J].
Behera, Millie A. ;
Dai, Qunsheng ;
Garde, Rachana ;
Saner, Carrie ;
Jungheim, Emily ;
Price, Thomas M. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 297 (05) :E1089-E1096
[6]   Tracing the cellular origin of cancer [J].
Blanpain, Cedric .
NATURE CELL BIOLOGY, 2013, 15 (02) :126-134
[7]   Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics [J].
Calcagno, Anna Maria ;
Salcido, Crystal D. ;
Gillet, Jean-Pierre ;
Wu, Chung-Pu ;
Fostel, Jennifer M. ;
Mumau, Melanie D. ;
Gottesman, Michael M. ;
Varticovski, Lyuba ;
Ambudkar, Suresh V. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (21) :1637-1652
[8]   Gene expression profiling of breast cell lines identifies potential new basal markers [J].
Charafe-Jauffret, E ;
Ginestier, C ;
Monville, F ;
Finetti, P ;
Adélaïde, J ;
Cervera, N ;
Fekairi, S ;
Xerri, L ;
Jacquemier, J ;
Birnbaum, D ;
Bertucci, F .
ONCOGENE, 2006, 25 (15) :2273-2284
[9]   Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature [J].
Charafe-Jauffret, Emmanuelle ;
Ginestier, Christophe ;
Iovino, Flora ;
Wicinski, Julien ;
Cervera, Nathalie ;
Finetti, Pascal ;
Hur, Min-Hee ;
Diebel, Mark E. ;
Monville, Florence ;
Dutcher, Julie ;
Brown, Marty ;
Viens, Patrice ;
Xerri, Luc ;
Bertucci, Francois ;
Stassi, Giorgio ;
Dontu, Gabriela ;
Birnbaum, Daniel ;
Wicha, Max S. .
CANCER RESEARCH, 2009, 69 (04) :1302-1313
[10]   Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4 [J].
Cittelly, D. M. ;
Finlay-Schultz, J. ;
Howe, E. N. ;
Spoelstra, N. S. ;
Axlund, S. D. ;
Hendricks, P. ;
Jacobsen, B. M. ;
Sartorius, C. A. ;
Richer, J. K. .
ONCOGENE, 2013, 32 (20) :2555-2564